Patient Monitoring in the Intensive Care Unit

Sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05847803
Collaborator
(none)
240
1
3.3
73.8

Study Details

Study Description

Brief Summary

a cross-sectional survey of nurses' perception of patient monitoring in the ICUs

Condition or Disease Intervention/Treatment Phase
  • Other: No intervention, questionnaire survey

Study Design

Study Type:
Observational
Anticipated Enrollment :
240 participants
Observational Model:
Case-Crossover
Time Perspective:
Cross-Sectional
Official Title:
Nurses' Perceptions of Patient Monitoring in the Intensive Care Unit: a Cross-sectional Study
Actual Study Start Date :
Feb 5, 2023
Anticipated Primary Completion Date :
Apr 30, 2023
Anticipated Study Completion Date :
May 15, 2023

Outcome Measures

Primary Outcome Measures

  1. clinical requirements of patient monitoring in ICUs [12 months of working]

    Assessed using a web-based 36-item survey questionnaire Patient Monitoring in the Intensive Care Unit

  2. Work-related flow in ICUs [12 months of working]

    Assessed using the Work-related Flow inventory (WOLF)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • registered nurses in the ICUs
Exclusion Criteria:

Contacts and Locations

Locations

Site City State Country Postal Code
1 SAHZhejiangU Hangzhou China 310009

Sponsors and Collaborators

  • Second Affiliated Hospital, School of Medicine, Zhejiang University

Investigators

  • Study Chair: Wen Gao, PhD, SAHZU

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Second Affiliated Hospital, School of Medicine, Zhejiang University
ClinicalTrials.gov Identifier:
NCT05847803
Other Study ID Numbers:
  • 20230110
First Posted:
May 8, 2023
Last Update Posted:
May 8, 2023
Last Verified:
Jan 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of May 8, 2023